Navigation Links
China Kangtai Cactus Biotech Announces Goal to Expand and Enhance Shareholder Communication
Date:5/26/2009

HARBIN, China, May 26 /PRNewswire-Asia-FirstCall/ -- China Kangtai Cactus Biotech Inc. (the "Company") (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products in China, announced today that they are preparing to significantly expand its shareholder and financial communication with the upcoming retention of an internationally-recognized investor relations firm. The Company has exhibited significant growth over the last year, despite the challenging broader economic environment, and understands the need to put in place an effective and professional investor relations program to communicate the Company's progress with current shareholders and the broader financial community.

    Our recent growth has been exhibited through the following statistics:

    -- First quarter revenues expanded to USD$3.3 million from USD$2.8
       million, representing quarter over quarter growth of approximately 18%;
    -- First quarter operating income grew to USD$880,530 from USD$721,695
       representing quarter over quarter growth of approximately 22%;
    -- Closed on an acquisition to significantly expand our future production
       capabilities from both the equipment and the raw material standpoint;
       and
    -- As of March 31, 2009 the Company maintained a strong balance sheet that
       consisted of USD$2.35 million of cash and no long term debt.

"We are very pleased with our operating performance and the future expansion plans that are in motion. We believe that with our current position in the market and the current stabilization in the Chinese economy that our shareholders will significantly benefit from increased investor communication and expanded market exposure." said Jinjiang Wang, President of China Kangtai Cactus. "We look forward to implementing a market awareness program and communicating our message w
'/>"/>

SOURCE China Kangtai Cactus Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... EMBARGOED FOR RELEASE UNTIL 2 P.M. ET, WEDNESDAY, ... of Mother’s Home to Gas Wells , PITTSBURGH, June 3, ... of natural gas wells drilled with hydraulic fracturing were more ... living farther from such wells, according to a University ... southwestern Pennsylvania birth records. , The finding does not ...
(Date:6/3/2015)... York, NY (PRWEB) June 03, 2015 ... agreed to pay $7.8 million to resolve a Risperdal ... Arkansas over tactics the company allegedly used to market ... County Circuit Court indicate that the Arkansas Attorney General ... part of the accord. The Risperdal settlement amounts to ...
(Date:6/3/2015)... 2015 Follow us on LinkedIn ... revolutionized disease treatment on account of their better mode ... such as rheumatoid arthritis. The industry is expected to ... small molecule drugs to biopharmaceuticals over the coming years. ... and gene therapies, and recombinant proteins has attracted industry ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Dr. Steven Reisman, ... Cardiac Diagnostic Center ( http://www.newyorkcardiac.com ) located in NYC, announced ... weekdays to his practice. In most cases, depending on the ... the day they call, they will be seen by a ... priority as a cardiologist is to ensure that people who ...
(Date:6/3/2015)... York, NY (PRWEB) June 03, 2015 ... strategic partnership to expand online and mobile access ... Board Review and Maintenance of Certification (MOC) activities. ... will market VeoMed’s innovative courses to Decker’s extensive ... professionals interested in purchasing access to VeoMed’s premier ...
Breaking Medicine News(10 mins):Health News:Fracking Proximity Associated with Lower Birth Weight 2Health News:Fracking Proximity Associated with Lower Birth Weight 3Health News:Fracking Proximity Associated with Lower Birth Weight 4Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2
... The Sanitizer, Game Allows Consumers to Zap Germs in the Water Just ... ... 20 Just in time for Memorial Day,integrated marketing communications agency, Fletcher ... BioGuard,s new UV sanitizing unit, BioLab UV ( http://www.biolabuv.com ). ...
... is a well known disease entity that has a wide ... the colonic blood supply is key to its development. However, ... causes ischemia of the bowel. This report describes the first ... and splenic veins. , This case report, from a ...
... not uncommon to find tissue that normally lines the stomach ... tissue has been identified in such diverse locations as the ... case, reported by a team led by Dr. Steven Paul ... the World Journal of Gastroenterology. , Typically, when this gastric ...
... no obvious effects on MKN-45 cells proliferation and apoptosis. At ... apoptosis improved. It may be that CO2 gas affected the ... by a team led by Professor Pei-Wu Yu. The research ... World Journal of Gastroenterology. , There is an ongoing debate ...
... and calm, according to a new study from the Population ... at about age 60, participants reported more feelings of ease ... John Mirowsky, professors of sociology, have published the findings in ... issue of Social Science and Medicine. The research was funded ...
... substantial financial income and the ... chance to change people,s lives, ... so,people are increasingly looking for new ways to make the ... Today, that,s,possible with the independent marketing opportunities provided by,Melaleuca, The ...
Cached Medicine News:Health News:Fletcher Martin Creates Interactive Game-Ad for BioLab(R) UV for BioGuard(R) 2Health News:Heterotopic gastric tissue simulating acute appendicitis 2Health News:With age comes a sense of peace and calm 2Health News:Lucrative Sales Opportunities Abound With Melaleuca, The Wellness Company(R) 2
(Date:6/3/2015)... , June 3, 2015  Lightlake Therapeutics ... addiction treatments based on its expertise in opioid ... Lightlake,s partner for treating opioid overdose with intranasal ... New Drug Application (NDA) to the United States ... spray formulation of naloxone, a drug intended to ...
(Date:6/3/2015)... 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... license agreement with AbbVie (NYSE: ABBV ) to ... with Halozyme,s ENHANZE ™ platform. ... will receive an initial $23 million payment, followed ... each of up to nine collaboration targets. These ...
(Date:6/3/2015)... 2015  VA North Texas Health Care System ... vBloc, a technology-based, scientifically advanced weight loss therapy.  ... called the Maestro® Rechargeable System that intermittently blocks ... involving food intake and processing between the brain ... customizable to meet the needs of a patient,s ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 3VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 3
Worn by many professional athletes, EpiTrain is our most popular elbow support....
EpiPoint is a dynamic elbow strap for tennis elbow and other overuse conditions....
... Mayo Clinic Elbow Brace, featuring an innovative ... stability and comfort while allowing for immobilization, ... the elbow. The sturdy metal uprights provide ... hold the brace in position, ensure patient ...
... AliMed® Turnbuckle Elbow Orthosis applies ... extension or flexion. Controls elbow contracture ... unbalanced muscle strength. Also good for ... turnbuckle is tightened to apply tension ...
Medicine Products: